Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simbrinza as Adjunctive Therapy to Duotrav in Glaucoma or Ocular Hypertension
NCT02730871Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Jun 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide, brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jun 2016; status: terminated.
02
Drugs
brinzolamidebrimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02730871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730871.